Pazoo, Inc. is a company focused on health, wellness and safety. Through our involvement in the burgeoning medical cannabis industry, our mission is to provide best-in-class laboratory testing of cannabis and cannabinoids to ensure quality and consistency that protects consumers from impurities, contaminants and other irregularities. Pazoo’s wholly-owned subsidiary, Harris Lee, and 40%-owned MA & Associates, offer industry-leading laboratory testing and analytics via an exclusive licensing agreement with global testing leader Steep Hill Labs, Inc. Pazoo's contract with Steep Hill allows us to use their premier, proprietary testing protocols on a right-of-first-refusal basis as we expand throughout the U.S. Pazoo is licensed to test cannabis in Nevada and Oregon, with a strategy of expansion into other states.
Additionally, Pazoo delivers a comprehensive array of empowering health and wellness information for people and their pets on its robust website, www.pazoo.com, featuring industry experts from both the health and wellness arena and pet care industry.
Market Value: $505,841 a/o Apr 21, 2017
Authorized Shares: 3,000,000,000 a/o Mar 30, 2017
Outstanding Shares: 2,529,206,807 a/o Mar 30, 2017
Shareholders of Record: 4,654 a/o Apr 21, 2016
Short Interest: 0 (-100%) Jan 31, 2017
Transfer Agent: VStock Transfer, LLC
Steven Basloe - President
David M. Cunic - CEO
Ben Hoehn - COO, Acting CFO